Finance
Infant ibuprofen recall from CVS, Walmart, Family Dollar
Several batches of liquid ibuprofen for infants are being recalled.
Tris Pharma is pulling some of its ibuprofen oral suspensions sold under brands from CVS Health, Walmart, and Family Dollar. The products may have a higher concentration of ibuprofen, which could harm infants, Tris Pharma said.
More information on the recall, including which specific lots are affected, is available in a statement from the company.
Ibuprofen is used to relieve pain or treat fevers. If infants are exposed to doses of the product that are too high, their kidneys could be permanently injured, Tris Pharma said. Side effects to watch for include nausea, vomiting, stomach pain and diarrhea.
Tris Pharma said it hasn’t received any reports of adverse events linked to the recalled products.
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
‘Shōgun’ co-creators break down the finale: ‘It’s a story about death’
Tesla’s new growth plan is centered around mysterious cheaper models
Tesla’s in trouble. Is Elon Musk the problem?
Two widow founders launch DayNew, a social platform for people dealing with grief and trauma
Google Pixel 9 and Pixel 9 Pro: Release date, specs, new features, and other rumors
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
Mood.camera is an iOS app that feels like using a retro analog camera
Furious Watcher fans are blasting it as ‘greedy’ over paid subscription service
Lenovo Yoga Book 9i review: A sick dual-screen laptop with life-changing productivity
API startup Noname Security nears $500M deal to sell itself to Akamai
US think tank Heritage Foundation hit by cyberattack
NASA discovered bacteria that wouldn’t die. Now it’s boosting sunscreen.
How to watch ‘Argylle’: When and where is it streaming?
Tesla drops prices, Meta confirms Llama 3 release, and Apple allows emulators in the App Store
Tesla layoffs hit high performers, some departments slashed, sources say
TechCrunch Mobility: Cruise robotaxis return and Ford’s BlueCruise comes under scrutiny
Maju Kuruvilla is out as CEO of one-click checkout company Bolt
Meta to close Threads in Turkey to comply with injunction prohibiting data-sharing with Instagram
Former top SpaceX exec Tom Ochinero sets up new VC firm, filings reveal
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
‘Shōgun’ co-creators break down the finale: ‘It’s a story about death’
Tesla’s new growth plan is centered around mysterious cheaper models
Tesla’s in trouble. Is Elon Musk the problem?
Two widow founders launch DayNew, a social platform for people dealing with grief and trauma
Google Pixel 9 and Pixel 9 Pro: Release date, specs, new features, and other rumors
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
Mood.camera is an iOS app that feels like using a retro analog camera
Furious Watcher fans are blasting it as ‘greedy’ over paid subscription service
Lenovo Yoga Book 9i review: A sick dual-screen laptop with life-changing productivity
-
Business7 days agoConsumer Financial Protection Bureau fines BloomTech for false claims
-
Business5 days agoLangdock raises $3M with General Catalyst to help businesses avoid vendor lock-in with LLMs
-
Entertainment5 days agoWhat Robert Durst did: Everything to know ahead of ‘The Jinx: Part 2’
-
Entertainment4 days agoThis nova is on the verge of exploding. You could see it any day now.
-
Business4 days agoIndia’s election overshadowed by the rise of online misinformation
-
Business4 days agoThis camera trades pictures for AI poetry
-
Business5 days agoCesiumAstro claims former exec spilled trade secrets to upstart competitor AnySignal
-
Business6 days agoScreen Skinz raises $1.5 million seed to create custom screen protectors
